Options traders are buying the dip in two stocks this morning, with Meta Platforms (NASDAQ:META) and Vistagen Therapeutics (NASDAQ:VTGN) drawing bullish options activity as both equities trade lower.
Meta Platforms stock is down 2.4% at $758.84 at last glance. Options traders appear to be taking advantage of the pullback, however, with META sporting a net positive option delta volume of 101,098 shares. Bullish positioning is equivalent to more than 1.5 million shares, compared to roughly 1.4 million shares on the bearish side.
Vistagen Therapeutics stock is down 5.1% to trade at $0.28. Despite the drop, options activity is overwhelmingly bullish, with the equity's net option delta volume sitting at a positive 39,484 shares. Positive delta volume represents the equivalent of 42,530 shares, compared to just 3,047 shares of negative delta volume.
| 5 hours | |
| 6 hours | |
| 7 hours | |
| 7 hours | |
| 8 hours | |
| 9 hours | |
| 10 hours |
Experts Weigh in on Whether Nvidia's Stock Worth Buying After Jensen Huang's Exit
META
International Business Times
|
| 10 hours | |
| 10 hours | |
| 11 hours | |
| 11 hours |
Meta's $27B Off-Balance-Sheet AI Deal Reminds Steve Eisman of Enron Joseph Carlson Disagrees
META
Benzinga Prediction Markets
|
| 11 hours | |
| 15 hours | |
| 15 hours | |
| 20 hours |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite